Thus, KDM4B enhances c-Myc's activity in AR positive PCa cells by at least two ways, 1) coactivating AR to drive c-Myc expression, and 2) coactivating c-Myc to drive the expression of target genes. The gene discussed is MYC; the disease is posterior cortical atrophy.